|
Volumn 62, Issue SUPPL. 13, 2001, Pages 39-46
|
Mental health care in Japan: Recognition and treatment of depression and anxiety disorders
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
AMITRIPTYLINE;
AMOXAPINE;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
BROMAZEPAM;
BROMOCRIPTINE MESILATE;
CHLORDIAZEPOXIDE;
CLOMIPRAMINE;
CLOTIAZEPAM;
CLOXAZOLAM;
DIAZEPAM;
DOSULEPIN;
FLUDIAZEPAM;
FLUVOXAMINE;
FLUVOXAMINE MALEATE;
IMIPRAMINE;
LITHIUM CARBONATE;
LOFEPRAMINE;
LORAZEPAM;
MAPROTILINE;
MEDAZEPAM;
MIANSERIN;
NORTRIPTYLINE;
OXAZEPAM;
OXAZOLAM;
PAROXETINE;
PRAZEPAM;
SEROTONIN UPTAKE INHIBITOR;
SULPIRIDE;
TECIPTILINE;
TRAZODONE;
TRIMIPRAMINE;
UNINDEXED DRUG;
ANXIETY NEUROSIS;
DEPRESSION;
ECONOMIC ASPECT;
HEALTH CARE QUALITY;
HUMAN;
JAPAN;
MENTAL HEALTH CARE;
MENTAL HEALTH SERVICE;
PRIORITY JOURNAL;
REVIEW;
SOCIAL ASPECT;
ANTIDEPRESSIVE AGENTS;
ANXIETY DISORDERS;
DELIVERY OF HEALTH CARE;
DEPRESSIVE DISORDER;
HOSPITALS, PRIVATE;
HOSPITALS, PSYCHIATRIC;
HUMANS;
JAPAN;
MENTAL HEALTH SERVICES;
PSYCHIATRY;
SEROTONIN UPTAKE INHIBITORS;
SOCIAL CHANGE;
SOCIOECONOMIC FACTORS;
TERMINOLOGY;
|
EID: 0034977625
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (23)
|
References (28)
|